These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 12052325)

  • 21. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists.
    Currie GP; Srivastava P; Dempsey OJ; Lee DK
    QJM; 2005 Mar; 98(3):171-82. PubMed ID: 15728398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Substances affecting the synthesis and activity of leukotrienes].
    Opletalová V; Hartl J; Bĕhounková M
    Ceska Slov Farm; 1997 Apr; 46(2):51-7. PubMed ID: 9244564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukotriene inhibitors and antagonists in asthma.
    Spector SL
    Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):463-70, 473; quiz 473-4. PubMed ID: 8603274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antileukotriene drugs: a new treatment for asthma].
    Armetti L; Nicosia S
    Boll Chim Farm; 1999 Dec; 138(11):599-605. PubMed ID: 10765473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotrienes, antileukotrienes and asthma.
    Montuschi P
    Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukotriene antagonists. Do they offer new hope for asthmatics?
    Thien F
    Aust Fam Physician; 2000 Jun; 29(6):547-51. PubMed ID: 10863810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukotrienes and their possible significance for the pathogenesis of asthma.
    Verhagen J; Bruynzeel PL
    Allergol Immunopathol (Madr); 1985; 13(6):531-7. PubMed ID: 3008545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Henriksen AH; Bjermer L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):647-51. PubMed ID: 9102953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in therapy with antileukotriene drugs.
    Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
    Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Leukotriene antagonists in the treatment of asthma].
    Mapp CE
    Ann Ital Med Int; 1998; 13(1):24-9. PubMed ID: 9642839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The leukotrienes.
    Stjernschantz J
    Med Biol; 1984; 62(4):215-30. PubMed ID: 6096644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leukotrienes. A review of the significance for disease in man and the possibilities for therapeutic intervention].
    Thomsen MK; Ahnfelt-Rønne I
    Ugeskr Laeger; 1991 Jan; 153(3):173-6. PubMed ID: 1998235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arachidonic acid metabolites: mediators of inflammation in asthma.
    Wenzel SE
    Pharmacotherapy; 1997; 17(1 Pt 2):3S-12S. PubMed ID: 9017783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukotriene receptor antagonists and related compounds.
    Wenzel SE
    Can Respir J; 1999; 6(2):189-93. PubMed ID: 10322101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antileukotriene agents in asthma: the dart that kills the elephant?
    Renzi PM
    CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of antileukotriene agents in asthma therapy.
    Gawchik SM; Saccar CL
    J Am Osteopath Assoc; 2000 Jan; 100(1):32, 37-43. PubMed ID: 10693315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
    Rask-Madsen J; Bukhave K; Laursen LS; Lauritsen K
    Agents Actions; 1992; Spec No():C37-46. PubMed ID: 1359745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.